01
8-Week Starter Pack
Starter option for clients beginning a provider-guided Tirzepatide program.
Program price*$800
Current Patient Refill →
Medical Weight Management
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist used in medical weight-management. Vydration offers provider-guided treatment options with appropriate consultation, screening, and individualized instructions.
How It Works
Provider-guided support built around your goals.
Tirzepatide works through GIP and GLP-1 receptor pathways involved in appetite, digestion, and metabolic regulation.
Eligibility, dosing, escalation, and follow-up should be determined by a licensed clinician based on your health history and response to treatment.
Compounded Tirzepatide is not FDA-approved and is not evaluated by the FDA for safety,
effectiveness, or quality in the same way as FDA-approved medications.
Is this your first time or a refill?
Choose the option that applies to you before continuing with GLP-1 treatment.
First-Time Patient
I am starting GLP-1 treatment with Vydration and need a medical evaluation.
Start Medical Evaluation →
Refill / Current Patient
I am an existing Vydration GLP-1 patient requesting my next treatment.
View Refill Options →
Refill requests remain subject to your current treatment plan, prescription status, and any provider review required for continued treatment.
Existing Vydration Patients
Current Patient Refill Options
These refill options are intended for existing Vydration patients. Continue only if you are already under a Vydration provider's GLP-1 treatment plan. New patients should complete the medical evaluation first.
Medical review required before treatment.
Tirzepatide is a prescription treatment. Completing a consultation does not guarantee eligibility or a prescription. If approved, your licensed provider will determine the appropriate treatment plan and dosing.
Tirzepatide is a prescription treatment. Completing a consultation does not guarantee eligibility or a prescription. If approved, your licensed provider will determine the appropriate treatment plan and dosing.
02
Monthly Package
Monthly Tirzepatide package with available dose selection on the product page.
Program price*$400
Current Patient Refill →
03
4 mL Single Vial
Single-vial Tirzepatide option for an eligible provider-guided treatment plan.
Program price*$800
Current Patient Refill →
Before You Begin
What to expect.
Medical Screening
Complete a health-history review and consultation with a licensed provider. Eligibility is determined before prescription treatment is initiated.
Weekly Treatment
When prescribed, Tirzepatide is generally used on a weekly schedule according to your clinician's instructions.
Ongoing Follow-Up
Your provider may adjust your treatment plan based on response, tolerance, and individual goals.
Questions before you start?
Book a consultation with the Vydration team to review eligibility and Tirzepatide options.
*Displayed pricing is program information and does not guarantee treatment or a prescription.
Prescription treatment requires medical evaluation, provider approval, and a valid prescription when clinically appropriate.
Medication is not dispensed before provider review. Individual results vary. Pricing and availability may change.